Abstract

OBJECTIVE:To determine whether there is any influence of systemic arterial hypertension on the peripheral auditory system.METHODS:This was a cross-sectional study that investigated 40 individuals between 30 and 50 years old, who were divided into groups with and without systemic arterial hypertension, using data from high-frequency audiometry, transient-evoked otoacoustic emissions and distortion-product otoacoustic emissions. The results were compared with those from groups of normal-hearing individuals, with and without systemic arterial hypertension, who underwent the pure-tone audiometry test. All individuals also underwent the following procedures: otoscopy, acoustic immittance measures, pure-tone audiometry at frequencies from 250 to 16000 Hz, transient-evoked otoacoustic emissions test and distortion-product otoacoustic emissions test.RESULTS:No statistically significant difference was observed between the groups with and without systemic arterial hypertension in either conventional or high-frequency audiometry. Regarding transient-evoked otoacoustic emissions, there was a trend toward statistical significance whereby the systemic arterial hypertension group showed lower results. Regarding distortion-product otoacoustic emissions, the systemic arterial hypertension group showed significantly lower results at the following frequencies: 1501, 2002, and 3003 Hz. A discriminant analysis indicated that the distortion-product otoacoustic emissions variables best distinguished individuals with and without systemic arterial hypertension.CONCLUSION:Data from this study suggest cochlear dysfunction in individuals with systemic arterial hypertension because their otoacoustic emission results were lower than those in the systemic arterial hypertension group.

Highlights

  • Systemic arterial hypertension (SAH) is a silent disease, some individuals experience headaches, dizziness, tinnitus, chest pain, and weakness associated with the condition

  • There was no statistically significant difference between ears when comparing conventional and highfrequency audiometry (Hotelling’s T2 test - p-value=0.54). For this analysis, the standard profile was that of a 43-year-old woman without systemic arterial hypertension (SAH) (Table 1)

  • Agarwal et al [8] evaluated three groups divided into different grades of SAH and the mean disease duration ranged from 3.7 to 9.0 years

Read more

Summary

Introduction

Systemic arterial hypertension (SAH) is a silent disease, some individuals experience headaches, dizziness, tinnitus, chest pain, and weakness associated with the condition. SAH may involve secondary hearing changes [1,2]. SAH could occur because these factors cause or potentiate hearing loss [6]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call